China Meheco Group Co.Ltd(600056) : the cooperation with covid-19 virus treatment drugs of a multinational pharmaceutical company is under negotiation

China Meheco Group Co.Ltd(600056) issued a risk warning announcement. The company is concerned about the recent rumors of cooperation between the company and covid-19 virus treatment drugs, a multinational pharmaceutical company. After verification by the company, relevant matters are under communication and negotiation, but there are still uncertainties about the specific terms of the agreement and whether it can be signed smoothly. In addition, even if the cooperation is carried out smoothly, the final use and sales of relevant drugs are also affected by factors such as epidemic prevention and control, there is great uncertainty, and it is expected that the relevant business scale accounts for a small proportion of the company’s overall business volume, which has no significant impact on the company’s recent operating performance. In view of the large fluctuation of the company’s share price recently, please pay attention to the trading risks in the secondary market, make rational decisions and invest prudently.

- Advertisment -